Arcadia Biosciences, Inc.
RKDA- Exchange
- Nasdaq
- Industry
- Crude Petroleum & Natural Gas
- SEC CIK
- 0001469443
No open-market purchases or sales by Arcadia Biosciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $146.5K in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Arcadia Biosciences, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 12 | 15 | +3 |
| Shares | 47.4K | 138.5K | +91.1K (+192.0%) |
| Value | $158.6K | $430.7K | +$272.2K (+171.6%) |
New holders (3)
Institutions that held Arcadia Biosciences, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Group Inc | 14,038 | $43.9K | 0.00% |
| Virtu Financial LLC | 11,370 | $34.0K | 0.00% |
| JPMorgan Chase & Co | 508 | $1.54K | 0.00% |
Sold out (0)
Institutions that held Arcadia Biosciences, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
None.